Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
58
AGFY Quote, Financials, Valuation and Earnings
Last price:
$24.51
Seasonality move
:
-23.18%
Day range:
$24.20 - $26.03
52-week range:
$2.71 - $84.44
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.29x
P/B ratio:
1.76x
Volume:
7.8K
Avg. volume:
19.5K
1-year change:
384.45%
Market cap:
$47.3M
Revenue:
$9.7M
EPS (TTM):
-$44.34
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $12.1M | $59.9M | $58.3M | $15.1M | $9.7M | |
| Revenue Growth (YoY) | 195.67% | 395.24% | -2.67% | -74.01% | -36.07% | |
| Cost of Revenues | $11.5M | $54.6M | $90.1M | $11.1M | $9M | |
| Gross Profit | $570K | $5.2M | -$31.8M | $4M | $665K | |
| Gross Profit Margin | 4.72% | 8.74% | -54.58% | 26.54% | 6.87% | |
| R&D Expenses | $3.4M | $3.9M | $8.2M | $2.3M | $743K | |
| Selling, General & Admin | $9.8M | $35M | $82.7M | $16.1M | $12.3M | |
| Other Inc / (Exp) | -$8.5M | $1.3M | -$56.9M | $3.1M | -$15.7M | |
| Operating Expenses | $13.2M | $38.9M | $90.9M | $18.4M | $13M | |
| Operating Income | -$12.6M | -$33.7M | -$122.7M | -$14.3M | -$12.4M | |
| Net Interest Expenses | $481K | -- | $8.8M | $2.1M | $256K | |
| EBT. Incl. Unusual Items | -$21.6M | -$32.3M | -$188.3M | -$13.4M | -$28.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -$5.2M | -$13.4M | |
| Income Tax Expense | -- | $25K | $23K | $2K | -$2K | |
| Net Income to Company | -$21.6M | -$32.5M | -$188.2M | -$18.6M | -$41.7M | |
| Minority Interest in Earnings | $22K | -$140K | $134K | $1K | -- | |
| Net Income to Common Excl Extra Items | -$21.6M | -$32.5M | -$188.2M | -$18.6M | -$41.7M | |
| Basic EPS (Cont. Ops) | -$5,423.89 | -$5,111.25 | -$13,532.85 | -$187.64 | -$40.92 | |
| Diluted EPS (Cont. Ops) | -$5,423.89 | -$5,111.25 | -$13,532.85 | -$187.64 | -$40.92 | |
| Weighted Average Basic Share | $4.1K | $6.4K | $13.9K | $99.4K | $1M | |
| Weighted Average Diluted Share | $4.1K | $6.4K | $13.9K | $99.4K | $1M | |
| EBITDA | -$12.2M | -$32.4M | -$119.6M | -$9.4M | -$26.7M | |
| EBIT | -$12.6M | -$33.7M | -$122.7M | -$11.3M | -$28.1M | |
| Revenue (Reported) | $12.1M | $59.9M | $58.3M | $15.1M | $9.7M | |
| Operating Income (Reported) | -$12.6M | -$33.7M | -$122.7M | -$14.3M | -$12.4M | |
| Operating Income (Adjusted) | -$12.6M | -$33.7M | -$122.7M | -$11.3M | -$28.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $7M | $26M | $5.8M | -- | $538K | |
| Revenue Growth (YoY) | 591.81% | 271.3% | -77.7% | -- | -- | |
| Cost of Revenues | $7.5M | $21.9M | $4.8M | -- | $448K | |
| Gross Profit | -$540K | $4.2M | $988K | -- | $90K | |
| Gross Profit Margin | -7.71% | 16.03% | 17.02% | -- | 16.73% | |
| R&D Expenses | $882K | $2.1M | $735K | $275K | -- | |
| Selling, General & Admin | $5.1M | $11.8M | $8.5M | $1.6M | $3.8M | |
| Other Inc / (Exp) | $2.7M | $10.8M | -$1.3M | $3.1M | $426K | |
| Operating Expenses | $6M | $13.9M | $9.3M | $1.8M | $3.8M | |
| Operating Income | -$6.5M | -$9.8M | -$8.3M | -$1.8M | -$3.7M | |
| Net Interest Expenses | $32K | -- | $799K | $100K | -- | |
| EBT. Incl. Unusual Items | -$3.8M | $1.6M | -$10.3M | $1.1M | -$3.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | $3.1M | $1.6M | |
| Income Tax Expense | -- | -$200K | -- | -- | -- | |
| Net Income to Company | -$3.8M | $1.8M | -$10.3M | $4.2M | -$1.6M | |
| Minority Interest in Earnings | $33K | -$1K | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$3.8M | $1.8M | -$10.3M | $4.2M | -$1.6M | |
| Basic EPS (Cont. Ops) | -$988.05 | $217.20 | -$144.45 | $7.15 | -$0.83 | |
| Diluted EPS (Cont. Ops) | -$988.05 | $206.85 | -$144.45 | $2.93 | -$0.83 | |
| Weighted Average Basic Share | $3.9K | $8.2K | $71.5K | $593K | $2M | |
| Weighted Average Diluted Share | $3.9K | $8.6K | $71.5K | $1.5M | $2M | |
| EBITDA | -$6.3M | -$8.7M | -$9.2M | -$1.4M | -$3.4M | |
| EBIT | -$6.5M | -$9.8M | -$9.5M | -$1.8M | -$3.7M | |
| Revenue (Reported) | $7M | $26M | $5.8M | -- | $538K | |
| Operating Income (Reported) | -$6.5M | -$9.8M | -$8.3M | -$1.8M | -$3.7M | |
| Operating Income (Adjusted) | -$6.5M | -$9.8M | -$9.5M | -$1.8M | -$3.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $18.1M | $78.9M | $38M | -- | $7.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $18.1M | $68.9M | $73M | -- | $7M | |
| Gross Profit | -$11K | $9.9M | -$35M | $3M | $590K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $3M | $5.1M | $6.8M | $1.8M | $468K | |
| Selling, General & Admin | $12.6M | $41.7M | $79.4M | $9.1M | $11.5M | |
| Other Inc / (Exp) | $2.7M | $9.4M | -$68.9M | $7.4M | -$24.3M | |
| Operating Expenses | $15.7M | $46.9M | $86.2M | $10.9M | $12M | |
| Operating Income | -$15.7M | -$36.9M | -$121.2M | -$7.9M | -$11.4M | |
| Net Interest Expenses | $518K | -- | $10.1M | $1.4M | $155K | |
| EBT. Incl. Unusual Items | -$22M | -$26.9M | -$200.2M | -$2M | -$35.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | $3.1M | $1.6M | |
| Income Tax Expense | -- | -$175K | $223K | -- | -- | |
| Net Income to Company | -$22M | -$26.9M | -$200.3M | -$4.1M | -$47.6M | |
| Minority Interest in Earnings | $24K | -$174K | $135K | $1K | -- | |
| Net Income to Common Excl Extra Items | -$22M | -$26.9M | -$200.3M | -$4.1M | -$47.6M | |
| Basic EPS (Cont. Ops) | -$5,538.20 | -$3,819.00 | -$15,850.82 | -$63.15 | -$44.34 | |
| Diluted EPS (Cont. Ops) | -$5,538.20 | -$3,829.35 | -$15,850.82 | -$67.37 | -$44.34 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$15.2M | -$34.7M | -$130.9M | -$1.2M | -$33.4M | |
| EBIT | -$15.7M | -$36.9M | -$133.2M | -$3.2M | -$34.9M | |
| Revenue (Reported) | $18.1M | $78.9M | $38M | -- | $7.6M | |
| Operating Income (Reported) | -$15.7M | -$36.9M | -$121.2M | -$7.9M | -$11.4M | |
| Operating Income (Adjusted) | -$15.7M | -$36.9M | -$133.2M | -$3.2M | -$34.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $7M | $26M | $5.8M | -- | $538K | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $7.5M | $21.9M | $4.8M | -- | $448K | |
| Gross Profit | -$540K | $4.2M | $988K | -- | $90K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $882K | $2.1M | $735K | $275K | -- | |
| Selling, General & Admin | $5.1M | $11.8M | $8.5M | $1.6M | $3.8M | |
| Other Inc / (Exp) | $2.7M | $10.8M | -$1.3M | $3.1M | $426K | |
| Operating Expenses | $6M | $13.9M | $9.3M | $1.8M | $3.8M | |
| Operating Income | -$6.5M | -$9.8M | -$8.3M | -$1.8M | -$3.7M | |
| Net Interest Expenses | $32K | -- | $799K | $100K | -- | |
| EBT. Incl. Unusual Items | -$3.8M | $1.6M | -$10.3M | $1.1M | -$3.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | $3.1M | $1.6M | |
| Income Tax Expense | -- | -$200K | -- | -- | -- | |
| Net Income to Company | -$3.8M | $1.8M | -$10.3M | $4.2M | -$1.6M | |
| Minority Interest in Earnings | $33K | -$1K | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$3.8M | $1.8M | -$10.3M | $4.2M | -$1.6M | |
| Basic EPS (Cont. Ops) | -$988.05 | $217.20 | -$144.45 | $7.15 | -$0.83 | |
| Diluted EPS (Cont. Ops) | -$988.05 | $206.85 | -$144.45 | $2.93 | -$0.83 | |
| Weighted Average Basic Share | $3.9K | $8.2K | $71.5K | $593K | $2M | |
| Weighted Average Diluted Share | $3.9K | $8.6K | $71.5K | $1.5M | $2M | |
| EBITDA | -$6.3M | -$8.7M | -$9.2M | -$1.4M | -$3.4M | |
| EBIT | -$6.5M | -$9.8M | -$9.5M | -$1.8M | -$3.7M | |
| Revenue (Reported) | $7M | $26M | $5.8M | -- | $538K | |
| Operating Income (Reported) | -$6.5M | -$9.8M | -$8.3M | -$1.8M | -$3.7M | |
| Operating Income (Adjusted) | -$6.5M | -$9.8M | -$9.5M | -$1.8M | -$3.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8.1M | $12M | $10.5M | $434K | $31.2M | |
| Short Term Investments | -- | $44.6M | $460K | $4K | -- | |
| Accounts Receivable, Net | $4M | $7.2M | $1.1M | $855K | $348K | |
| Inventory | $4.3M | $18.3M | $5.9M | $5M | $1.6M | |
| Prepaid Expenses | $1M | $3.4M | $16.1M | $1.5M | $1.4M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $18.6M | $86.7M | $44.9M | $24M | $34.7M | |
| Property Plant And Equipment | $873K | $7.7M | $12.3M | $1.1M | $690K | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $632K | $50.1M | -- | -- | $9.7M | |
| Other Intangibles | $1.7M | $14.1M | -- | -- | $8.9M | |
| Other Long-Term Assets | -- | -- | -- | $20.1M | -- | |
| Total Assets | $21.8M | $182M | $69.7M | $45.3M | $54M | |
| Accounts Payable | $693K | $9.2M | $20.5M | $4.4M | $2.1M | |
| Accrued Expenses | $5.9M | $19.8M | $7.9M | $3M | $1.5M | |
| Current Portion Of Long-Term Debt | -- | $1.1M | $28.8M | $5.2M | $10.5M | |
| Current Portion Of Capital Lease Obligations | $148K | $970K | $886K | $207K | $261K | |
| Other Current Liabilities | $7.5M | $48K | $127K | $20.2M | -- | |
| Total Current Liabilities | $27M | $43.6M | $70.6M | $41.2M | $24.7M | |
| Long-Term Debt | $829K | $12K | $407K | $16M | $1K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $28.3M | $44.6M | $78.7M | $60M | $25.9M | |
| Common Stock | $4K | -- | $1K | -- | $2K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -$6.7M | $137.1M | -$9.3M | -$14.9M | $27.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $225K | $365K | $231K | $230K | $230K | |
| Total Equity | -$6.5M | $137.4M | -$9M | -$14.7M | $28.1M | |
| Total Liabilities and Equity | $21.8M | $182M | $69.7M | $45.3M | $54M | |
| Cash and Short Terms | $8.1M | $56.6M | $10.9M | $434K | $31.2M | |
| Total Debt | $13.3M | $1.1M | $29.2M | $21.3M | $10.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $137.9M | $25.2M | $1.5M | $95K | $24.4M | |
| Short Term Investments | -- | $38.2M | $4K | $4K | -- | |
| Accounts Receivable, Net | $9.2M | $8.6M | $1.2M | $211K | $381K | |
| Inventory | $8.5M | $28.2M | $6M | $18M | $738K | |
| Prepaid Expenses | $2.4M | $14.2M | $16.6M | $1.3M | $1.3M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $158.1M | $147.5M | $25.7M | $20.9M | $27.2M | |
| Property Plant And Equipment | $1.1M | $8.6M | $12M | $9M | -- | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $632K | $54.5M | -- | -- | $9.7M | |
| Other Intangibles | $1.6M | $15.9M | -- | -- | $8.6M | |
| Other Long-Term Assets | -- | -- | -- | $99K | $120K | |
| Total Assets | $161.5M | $264.5M | $50.6M | $40.9M | $45.6M | |
| Accounts Payable | $878K | $3.7M | $21.1M | $12.4M | $1.1M | |
| Accrued Expenses | $12.5M | $21.1M | $5.8M | $2.2M | $2.2M | |
| Current Portion Of Long-Term Debt | -- | $3M | $2.1M | $3.1M | $615K | |
| Current Portion Of Capital Lease Obligations | $222K | $1.1M | $955K | $615K | -- | |
| Other Current Liabilities | -- | -- | -- | -- | $3M | |
| Total Current Liabilities | $14.2M | $41.9M | $39.9M | $27.7M | $18.2M | |
| Long-Term Debt | $831K | $51.2M | $22.6M | $21.2M | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $15.4M | $94M | $67.6M | $50.6M | $18.8M | |
| Common Stock | $19K | $25K | $1K | $13K | $2K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $192K | $366K | $231K | $230K | -- | |
| Total Equity | $146.1M | $170.4M | -$16.9M | -$9.7M | $26.8M | |
| Total Liabilities and Equity | $161.5M | $264.5M | $50.6M | $40.9M | $45.6M | |
| Cash and Short Terms | $137.9M | $63.4M | $1.5M | $99K | $24.4M | |
| Total Debt | $831K | $54.1M | $24.6M | $24.3M | $10.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$21.6M | -$32.5M | -$188.2M | -$18.6M | -$41.7M | |
| Depreciation & Amoritzation | $407K | $1.3M | $3M | $1.9M | $1.4M | |
| Stock-Based Compensation | $1.9M | $5.6M | $4.3M | $2.7M | $1.2M | |
| Change in Accounts Receivable | -$3.7M | -$3.4M | $1.5M | $1.3M | $646K | |
| Change in Inventories | -$2.9M | -$6.6M | -$30.2M | $17.2M | $8.3M | |
| Cash From Operations | -$14.8M | -$30.1M | -$72M | -$31M | -$11.6M | |
| Capital Expenditures | $136K | $2.3M | $8.1M | $59K | $4K | |
| Cash Acquisitions | -$1.1M | -$35.9M | -$3.5M | -- | -- | |
| Cash From Investing | -$1.2M | -$104.7M | -$2.3M | $25.2M | -$54K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $13.9M | -- | $61.8M | $4.4M | $14.5M | |
| Long-Term Debt Repaid | -$88K | -$148K | -$38.1M | -$11.8M | -$377K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $40K | -- | -- | -- | -- | |
| Cash From Financing | $23.9M | $138.8M | $72.8M | -$4.2M | $42.4M | |
| Beginning Cash (CF) | $206K | $8.1M | $12M | $10.5M | $434K | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $7.9M | $3.9M | -$1.6M | -$10M | $30.7M | |
| Ending Cash (CF) | $8.1M | $12M | $10.5M | $434K | $31.2M | |
| Levered Free Cash Flow | -$14.9M | -$32.5M | -$80.2M | -$31M | -$11.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$3.8M | $1.8M | -$10.3M | $4.2M | -$1.6M | |
| Depreciation & Amoritzation | $147K | $1.1M | $312K | $406K | $336K | |
| Stock-Based Compensation | $2.1M | $953K | $859K | $490K | $589K | |
| Change in Accounts Receivable | -$5.2M | -$838K | -$127K | $296K | -$335K | |
| Change in Inventories | -$3.3M | -$16.4M | $1.4M | $861K | $662K | |
| Cash From Operations | -$7.3M | -$30.9M | -$9.5M | -$3M | -$6.7M | |
| Capital Expenditures | $142K | $3.7M | $59K | $2K | -- | |
| Cash Acquisitions | -- | -$3.5M | -- | -- | -- | |
| Cash From Investing | -$142K | -$13.4M | $9.8M | $328K | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $62.4M | -- | $355K | -- | |
| Long-Term Debt Repaid | -$47K | -$782K | -$10.8M | -$157K | -$1K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $137.2M | $87.4M | -$9.3M | $2.3M | -$1K | |
| Beginning Cash (CF) | $8.1M | $12M | $10.5M | $430K | $31.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $129.8M | $43.2M | -$9M | -$335K | -$6.7M | |
| Ending Cash (CF) | $137.9M | $55.2M | $1.5M | $95K | $24.4M | |
| Levered Free Cash Flow | -$7.4M | -$34.6M | -$9.5M | -$3M | -$6.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$22M | -$26.9M | -$200.3M | -$4.1M | -$47.6M | |
| Depreciation & Amoritzation | $488K | $2.2M | $2.3M | $2M | $1.4M | |
| Stock-Based Compensation | $4M | $4.4M | $4.2M | $2.3M | $1.3M | |
| Change in Accounts Receivable | -$9M | $989K | $2.3M | $1.8M | $15K | |
| Change in Inventories | -$5M | -$19.6M | -$12.5M | $16.6M | $8.1M | |
| Cash From Operations | -$18.1M | -$53.7M | -$50.6M | -$24.5M | -$15.3M | |
| Capital Expenditures | $219K | $5.9M | $4.5M | $2K | $2K | |
| Cash Acquisitions | $4K | -$39.4M | -$4K | -- | -- | |
| Cash From Investing | -$215K | -$118M | $20.8M | $15.7M | -$382K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $13.9M | $62.4M | -$588K | $4.8M | $14.1M | |
| Long-Term Debt Repaid | -$135K | -$883K | -$48.1M | -$1.1M | -$221K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $155M | $89M | -$24M | $7.4M | $40M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $136.7M | -$82.7M | -$53.7M | -$1.4M | $24.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$18.4M | -$59.7M | -$55.1M | -$24.5M | -$15.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$3.8M | $1.8M | -$10.3M | $4.2M | -$1.6M | |
| Depreciation & Amoritzation | $147K | $1.1M | $312K | $406K | $336K | |
| Stock-Based Compensation | $2.1M | $953K | $859K | $490K | $589K | |
| Change in Accounts Receivable | -$5.2M | -$838K | -$127K | $296K | -$335K | |
| Change in Inventories | -$3.3M | -$16.4M | $1.4M | $861K | $662K | |
| Cash From Operations | -$7.3M | -$30.9M | -$9.5M | -$3M | -$6.7M | |
| Capital Expenditures | $142K | $3.7M | $59K | $2K | -- | |
| Cash Acquisitions | -- | -$3.5M | -- | -- | -- | |
| Cash From Investing | -$142K | -$13.4M | $9.8M | $328K | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $62.4M | -- | $355K | -- | |
| Long-Term Debt Repaid | -$47K | -$782K | -$10.8M | -$157K | -$1K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $137.2M | $87.4M | -$9.3M | $2.3M | -$1K | |
| Beginning Cash (CF) | $8.1M | $12M | $10.5M | $430K | $31.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $129.8M | $43.2M | -$9M | -$335K | -$6.7M | |
| Ending Cash (CF) | $137.9M | $55.2M | $1.5M | $95K | $24.4M | |
| Levered Free Cash Flow | -$7.4M | -$34.6M | -$9.5M | -$3M | -$6.7M | |
Get AGFY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AGFY
Sector
P/E ratio
--
18.58x
PEG ratio
--
0.25x
P/B ratio
1.76x
1.75x
Price / LTM sales
4.29x
0.94x
Growth Metrics
AGFY
Sector
Revenue growth
90.12%
1.98%
Earnings growth
--
2.46%
Revenue (5-year growth)
18.82%
4.35%
Earnings forecast
--
$0.40
Profitability
AGFY
Sector
Profitability FY 2024
$665K
$393.9M
Return on invested capital
-202.82%
5.32%
Return on assets
-108.77%
3.49%
Return on equity
-402.52%
8.55%
Earnings Date
Last Earnings Date
Mar
21
Next Earnings Date
Aug
14
Estimated Next Earnings Date
Jun
20
Balance Sheet
AGFY
Sector
Total cash
$24.4M
$154.3M
Short term investments
$4K
$35.5M
Total assets
$54M
$1.7B
Long term debt
$10.6M
$252.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
